Literature DB >> 33622980

Pulmonary fibrosis screening: quantifying the psychological impact.

Chad A Newton1.   

Abstract

Entities:  

Keywords:  idiopathic pulmonary fibrosis; psychology

Year:  2021        PMID: 33622980      PMCID: PMC8222075          DOI: 10.1136/thoraxjnl-2021-216863

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  12 in total

1.  MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis.

Authors:  Susan K Mathai; Stephen Humphries; Jonathan A Kropski; Timothy S Blackwell; Julia Powers; Avram D Walts; Cheryl Markin; Julia Woodward; Jonathan H Chung; Kevin K Brown; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha Fingerlin; Ivana V Yang; David A Lynch; David A Schwartz
Journal:  Thorax       Date:  2019-09-26       Impact factor: 9.139

2.  Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.

Authors:  Gary M Hunninghake; Luisa D Quesada-Arias; Nikkola E Carmichael; Jose M Martinez Manzano; Sergio Poli De Frías; Maura Alvarez Baumgartner; Lisa DiGianni; Shannon N Gampala-Sagar; Dominick A Leone; Swati Gulati; Souheil El-Chemaly; Hilary J Goldberg; Rachel K Putman; Hiroto Hatabu; Benjamin A Raby; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

3.  High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Eric A Hoffman; Hilary F Armstrong; John H M Austin; Robert C Basner; Matthew N Bartels; Jason D Christie; Paul L Enright; Bernadette R Gochuico; Karen Hinckley Stukovsky; Joel D Kaufman; P Hrudaya Nath; John D Newell; Scott M Palmer; Dan Rabinowitz; Ganesh Raghu; Jessica L Sell; Jered Sieren; Sushil K Sonavane; Russell P Tracy; Jubal R Watts; Kayleen Williams; Steven M Kawut; David J Lederer
Journal:  Eur Respir J       Date:  2016-07-28       Impact factor: 16.671

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

Review 5.  Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.

Authors:  Dejana Braithwaite; Jon Emery; Fiona Walter; A Toby Prevost; Stephen Sutton
Journal:  J Natl Cancer Inst       Date:  2004-01-21       Impact factor: 13.506

6.  Association Between Interstitial Lung Abnormalities and All-Cause Mortality.

Authors:  Rachel K Putman; Hiroto Hatabu; Tetsuro Araki; Gunnar Gudmundsson; Wei Gao; Mizuki Nishino; Yuka Okajima; Josée Dupuis; Jeanne C Latourelle; Michael H Cho; Souheil El-Chemaly; Harvey O Coxson; Bartolome R Celli; Isis E Fernandez; Oscar E Zazueta; James C Ross; Rola Harmouche; Raúl San José Estépar; Alejandro A Diaz; Sigurdur Sigurdsson; Elías F Gudmundsson; Gudny Eiríksdottír; Thor Aspelund; Matthew J Budoff; Gregory L Kinney; John E Hokanson; Michelle C Williams; John T Murchison; William MacNee; Udo Hoffmann; Christopher J O'Donnell; Lenore J Launer; Tamara B Harrris; Vilmundur Gudnason; Edwin K Silverman; George T O'Connor; George R Washko; Ivan O Rosas; Gary M Hunninghake
Journal:  JAMA       Date:  2016-02-16       Impact factor: 56.272

Review 7.  A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.

Authors:  Jodi T Heshka; Crystal Palleschi; Heather Howley; Brenda Wilson; Philip S Wells
Journal:  Genet Med       Date:  2008-01       Impact factor: 8.822

8.  Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals.

Authors:  Nikkola Carmichael; Jose M Martinez Manzano; Luisa D Quesada-Arias; Sergio de Frías Poli; Maura Alvarez Baumgartner; Maria A Planchart Ferretto; Lisa DiGianni; Shannon Gampala-Sagar; Dominick A Leone; Swati Gulati; Souheil Y El-Chemaly; Hilary J Goldberg; Rachel Putman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake; Benjamin A Raby
Journal:  Thorax       Date:  2021-01-22       Impact factor: 9.102

9.  Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.

Authors:  Kate Brain; Kate J Lifford; Ben Carter; Olivia Burke; Fiona McRonald; Anand Devaraj; David M Hansell; David Baldwin; Stephen W Duffy; John K Field
Journal:  Thorax       Date:  2016-07-28       Impact factor: 9.139

10.  Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.

Authors:  Martin Kolb; Luca Richeldi; Jürgen Behr; Toby M Maher; Wenbo Tang; Susanne Stowasser; Christoph Hallmann; Roland M du Bois
Journal:  Thorax       Date:  2016-09-26       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.